Sign in

CIK 0001683553 · Non-accelerated filer<br>Smaller reporting company

SPRUCE BIOSCIENCES, INC.

Sign in to watch
Ticker
SPRB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
812154263
Phone
(415) 655-4168
Business address
611 GATEWAY BOULEVARD, SUITE 740, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-10-14 Novo Holdings A/S 10% owner Conversion · SERIES B CONVERTIBLE PREFERRED STOCK −10,000,000 0
2020-10-14 Muralidhar Bali Director Conversion +1,592,518 1,592,518
2020-10-14 Muralidhar Bali Director Purchase +200,000 $15.00 $3.0M 1,792,518
2020-10-14 Muralidhar Bali Director Conversion · Series B Preferred Stock −10,416,666 0
2020-10-14 O'Donnell Niall Director Conversion +445,905 445,905
2020-10-14 O'Donnell Niall Director Purchase +250,000 $15.00 $3.8M 695,905
2020-10-14 O'Donnell Niall Director Conversion · Series B Preferred Stock −2,916,664 0
2020-10-14 Omega Fund VI, L.P. Former 10% Owner Conversion +1,911,022 1,911,022
2020-10-14 Omega Fund VI, L.P. Former 10% Owner Purchase +250,000 $15.00 $3.8M 2,161,022
2020-10-14 Omega Fund VI, L.P. Former 10% Owner Conversion · Series B Preferred Stock −12,500,000 0
2020-10-14 Chaya Moghrabi Dina Director Conversion +1,911,022 1,911,022
2020-10-14 Chaya Moghrabi Dina Director Purchase +250,000 $15.00 $3.8M 2,161,022
2020-10-14 Chaya Moghrabi Dina Director Conversion · Series B Preferred Stock −12,500,000 0
2020-10-14 HealthCap VIII, L.P. Former 10% Owner Conversion +1,783,621 1,783,621
2020-10-14 HealthCap VIII, L.P. Former 10% Owner Purchase +250,000 $15.00 $3.8M 2,033,621
2020-10-14 HealthCap VIII, L.P. Former 10% Owner Conversion · Series B Preferred Stock −11,666,666 0
2020-10-14 HANSSON JONAS Director Conversion +1,783,621 1,783,621
2020-10-14 HANSSON JONAS Director Purchase +250,000 $15.00 $3.8M 2,033,621
2020-10-14 HANSSON JONAS Director Conversion · Series B Preferred Stock −11,666,666 0
2020-10-14 RiverVest Venture Fund III, L.P. 10% owner Conversion +1,070,172 1,070,172

Page 13 of 14 · 264 trades